On August 15, Shi Yuanyuan, chairman of Shenzhen Cell Valley, and Yang Yiqing, R&D scientist, went to Guangzhou R&F Hospital and had an in-depth exchange on the innovative development and application prospects of immune cell therapy with Chen Tao, director of immunotherapy of the Cancer Center of Excellence of the hospital and his team

                                  

At the exchange meeting, Director Chen Tao first introduced the construction and diagnosis and treatment concept of Guangzhou R&F Hospital, pointing out that Guangzhou R&F Hospital is an international general hospital operating in line with the double certification standards of "international medical standards" and "International medical information management standards". The two sides discussed the latest research results, technological advances and market trends in the field of immune cell therapy, aiming to find cooperation opportunities and jointly promote the emerging development of the cell therapy industry. Professor Shi Yuanyuan pointed out that the core research and development team of Shenzhen Cell Valley successfully used self-produced industrial-grade retrovirus vectors to prepare CAR-T cell products targeting more than 50 targets. The product has high transduction efficiency and high release standards, and has shown excellent safety and effectiveness in clinical studies of a number of medical institutions in China, truly achieving "cell benefit sentient beings".

Director Chen Tao praised Shenzhen Cell Valley's core technology and its corporate vision, and pointed out that he had visited Shenzhen Cell Valley's Shenzhen headquarters before. The purpose of this invitation is to achieve deeper cooperation with Cell Valley in the field of immune cell therapy through a field visit to our hospital.

Through this visit, both parties hope to establish a long-term and comprehensive cooperative relationship to jointly address industry challenges, promote the wide application of immune cell therapy technology, and bring more treatment options and hope to patients.

Guangzhou R&F Hospital is a high-end non-public international general hospital with an investment of more than 3 billion yuan. It is designed and built by UCLA Health Medical Center, a top international medical institution, and introduces cutting-edge medical facilities and equipment of international brands, including experts subsidized by The State Council. Top authoritative expert team from large domestic top three and internationally renowned hospitals. The oncology professional team set up in the hospital is composed of well-known experts and nursing teams from major tumor centers and oncology specialties. The department focuses on chemotherapy, targeted therapy and immunotherapy to provide patients with comprehensive treatment, high-end diagnosis and treatment technology and multi-disciplinary cooperative diagnosis and treatment mode, and develops the most advanced personalized, humanized high-quality precision treatment plan for each tumor patient. It is also equipped with warm and comfortable nursing services, providing the whole process services from tumor health education, diagnosis and treatment to rehabilitation and mental health consultation.